Guela, Mario E.

HRN: 28-88-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2026
CEFTRIAXONE 1G (VIAL)
04/18/2026
04/24/2026
IV
2G
OD
Cap-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: